Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice
中国医学科学杂志(英文版)2011年第2期 页码:91-97
• Original Article •|Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice
Affiliations:
1. Department of Hematology, General Hospital of the Chinese People’s Liberation Army,Beijing,China,100853
2. Department of Hematology, Shenyang Military General Hospital,Shenyang,China,110016
Author bio:
Funds:
DOI:
中图分类号:
网络出版日期:2011-06-24,
纸质出版日期:2011
Accepted:
Scan QR Code
Jing-hua Liu, Li-ping Dou, Li-xin Wang, 等. Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice[J]. 中国医学科学杂志(英文版), 2011,(2):91-97.
Jing-hua Liu, Li-ping Dou, Li-xin Wang, et al. Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice[J]. Chinese medical sciences journal, 2011, (2): 91-97.
Jing-hua Liu, Li-ping Dou, Li-xin Wang, 等. Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice[J]. 中国医学科学杂志(英文版), 2011,(2):91-97.DOI:
Jing-hua Liu, Li-ping Dou, Li-xin Wang, et al. Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice[J]. Chinese medical sciences journal, 2011, (2): 91-97.DOI:
Alpha-GalCer Administration after Allogeneic Bone Marrow Transplantation Improves Immune Reconstitution in Mice
Objective To explore the effect of α- galactosyleramide( α-GalCer ) on immune reconstitution under acute graft-versus-host disease (aGVHD). Methods BALB/c mice were transplanted wit hallogeneic C57BL/6 bone marrow cells and splenocytes (both 1×10
7
)after receiving lethal total-body irradiation. α-GalCer (100 ug/kg) or vehicle (dimethylsulfoxide) was administered intraperitoneally immediately after transplantation. The effects of α-GalCer on immune reconstitution
proliferation of T cells and B cells
hematopoiesis
and thymic microenvironment were assessed. Results The α-GalCer group exhibited higher percentages of CD3
+
CD4
+
CD8
+
B220
+
CD40
+
and CD86
+
cells compared with the vehicle group . The number of colony forming unit per 1000 CD34
+
cells in the α-GalCer group was higher than in the vehicle group ( P=0.0012).In vitro proliferation assays showed that the α-GalCer group had higher percentages of CD3
+
CD4
+
CD8
+
and B220
+
cells compared with the vehicle group. As for the results of in vivo proliferation assays
the numbers of CD3
+
CD4
+
CD8
+
and B220
+
cells were higher in the α-GalCer group than in the normal group
especially the number of B220
+
cells ( P=0.007).Significant difference was not found in thymocyte count between the α-GalCer group and the vehicle group
nor in the percentages of CD3
+
CD4
+
and CD8
+
cells.Conclusion Administration of α-GalCer after allogeneic bone marrow transplantation may promote immune reconstitution in the presence of aGVHD.
Abstract
Objective To explore the effect of α- galactosyleramide( α-GalCer ) on immune reconstitution under acute graft-versus-host disease (aGVHD). Methods BALB/c mice were transplanted wit hallogeneic C57BL/6 bone marrow cells and splenocytes (both 1×10
7
)after receiving lethal total-body irradiation. α-GalCer (100 ug/kg) or vehicle (dimethylsulfoxide) was administered intraperitoneally immediately after transplantation. The effects of α-GalCer on immune reconstitution
proliferation of T cells and B cells
hematopoiesis
and thymic microenvironment were assessed. Results The α-GalCer group exhibited higher percentages of CD3
+
CD4
+
CD8
+
B220
+
CD40
+
and CD86
+
cells compared with the vehicle group . The number of colony forming unit per 1000 CD34
+
cells in the α-GalCer group was higher than in the vehicle group ( P=0.0012).In vitro proliferation assays showed that the α-GalCer group had higher percentages of CD3
+
CD4
+
CD8
+
and B220
+
cells compared with the vehicle group. As for the results of in vivo proliferation assays
the numbers of CD3
+
CD4
+
CD8
+
and B220
+
cells were higher in the α-GalCer group than in the normal group
especially the number of B220
+
cells ( P=0.007).Significant difference was not found in thymocyte count between the α-GalCer group and the vehicle group
nor in the percentages of CD3
+
CD4
+
and CD8
+
cells.Conclusion Administration of α-GalCer after allogeneic bone marrow transplantation may promote immune reconstitution in the presence of aGVHD.